1502-45-0 Usage
General Description
N-(2-Aminoethyl)benzamide HCl, also known as N-(2-AEBA) HCl, is a chemical compound with a white crystalline appearance. It is a salt form of N-(2-AEBA), which is an organic molecule with potential biological activity. N-(2-AMinoethyl)benzaMide HCl is commonly used in laboratory research and pharmaceutical applications, where it is used to study the effects of benzamide analogs on various biological processes. N-(2-AEBA) HCl is also being investigated for its potential use in developing new therapies for conditions such as cancer, neurological disorders, and metabolic diseases. Additionally, it is also used as a precursor in the production of other chemical compounds. However, it is important to handle this substance with caution, as it may have potential health hazards if not used properly.
Check Digit Verification of cas no
The CAS Registry Mumber 1502-45-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,5,0 and 2 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1502-45:
(6*1)+(5*5)+(4*0)+(3*2)+(2*4)+(1*5)=50
50 % 10 = 0
So 1502-45-0 is a valid CAS Registry Number.
InChI:InChI=1/C9H12N2O/c10-6-7-11-9(12)8-4-2-1-3-5-8/h1-5H,6-7,10H2,(H,11,12)
1502-45-0Relevant articles and documents
New analogues of N-(2-aminoethyl)-4-chlorobenzamide (Ro 16-6491). Some of the most potent monoamine oxidase-B inactivators
Annan,Silverman
, p. 3968 - 3970 (1993)
A series of halo- and nitro-substituted analogues of N-(2- aminoethyl)benzamide has been synthesized. All of the compounds are competitive, time-dependent inhibitors of monoamine oxidase-B (MAO-B), but upon dialysis complete return of enzyme activity is observed for all compounds. Therefore, these are mechanism-based reversible inhibitors of MAO- B. The relative potencies of the compounds are rationalized in terms of steric and hydrophobic effects.
BENZOIMIDAZOLE DERIVATIVES AND GLYCOGEN SYNTHASE KINASE-3 BETA INHIBITORS CONTAINING THE SAME
-
Page/Page column 81, (2010/04/03)
Benzoimidazole Derivatives are provided. The compounds of the present invention are useful for Glycogen Synthase Kinase-3 Beta Inhibitors.
BENZAMIDE DERIVATIVES
-
, (2008/06/13)
Benzamides of the formula I wherein R1 and R2 each independently is hydrogen, halogen, lower alkyl, lower alkoxy, cyano, trifluoromethyl, sulfamoyl, mono(lower alkyl)sulfamoyl or di(lower alkyl)sulfamoyl or R1 and R2 on adjacent carbon atoms together are
